Safety And Efficacy Of Tofacitinib In Patients With Refractory Myasthenia Gravis: A Pilot Study

NCT04431895 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Myasthenia Gravis, Generalized

Interventions

DRUG: Tofacitinib 5 MG

Sponsor

Huashan Hospital